Comorbid conditions as predictors of mortality in severe COPD - an eight-year follow-up cohort study.

IF 1.8 Q3 RESPIRATORY SYSTEM
Gabriella Eliasson, Christer Janson, Gunnar Johansson, Kjell Larsson, Anders Lindén, Claes-Göran Löfdahl, Thomas Sandström, Josefin Sundh
{"title":"Comorbid conditions as predictors of mortality in severe COPD - an eight-year follow-up cohort study.","authors":"Gabriella Eliasson,&nbsp;Christer Janson,&nbsp;Gunnar Johansson,&nbsp;Kjell Larsson,&nbsp;Anders Lindén,&nbsp;Claes-Göran Löfdahl,&nbsp;Thomas Sandström,&nbsp;Josefin Sundh","doi":"10.1080/20018525.2023.2181291","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Co-morbidities are common in chronic obstructive pulmonary disease (COPD) and are associated with increased morbidity and mortality. The aim of the present study was to explore the prevalence of several comorbid conditions in severe COPD, and to investigate and compare their associations with long-term mortality.</p><p><strong>Methods: </strong>In May 2011 to March 2012, 241 patients with COPD stage 3 or 4 were included in the study. Information was collected on sex, age, smoking history, weight and height, current pharmacological treatment, number of exacerbations the recent year and comorbid conditions. At December 31st, 2019, mortality data (all-cause and cause specific) were collected from the National Cause of Death Register. Data were analyzed using Cox-regression analysis with gender, age, previously established predictors of mortality and comorbid conditions as independent variables, and all-cause mortality and cardiac and respiratory mortality, respectively, as dependent variables.</p><p><strong>Results: </strong>Out of 241 patients, 155 (64%) were deceased at the end of the study period; 103 patients (66%) died of respiratory disease and 25 (16%) of cardiovascular disease. Impaired kidney function was the only comorbid condition independently associated with increased all-cause mortality (HR (95% CI) 3.41 (1.47-7.93) p=0.004) and respiratory mortality (HR (95%CI) 4.63 (1.61 to 13.4), p = 0.005). In addition, age ≥70, BMI <22 and lower FEV1 expressed as %predicted were significantly associated with increased all-cause and respiratory mortality.</p><p><strong>Conclusion: </strong>In addition to the risk factors high age, low BMI and poor lung function; impaired kidney function appears to be an important risk factor for mortality in the long term, which should be taken into account in the medical care of patients with severe COPD.</p>","PeriodicalId":11872,"journal":{"name":"European Clinical Respiratory Journal","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d3/d2/ZECR_10_2181291.PMC9970194.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Clinical Respiratory Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20018525.2023.2181291","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: Co-morbidities are common in chronic obstructive pulmonary disease (COPD) and are associated with increased morbidity and mortality. The aim of the present study was to explore the prevalence of several comorbid conditions in severe COPD, and to investigate and compare their associations with long-term mortality.

Methods: In May 2011 to March 2012, 241 patients with COPD stage 3 or 4 were included in the study. Information was collected on sex, age, smoking history, weight and height, current pharmacological treatment, number of exacerbations the recent year and comorbid conditions. At December 31st, 2019, mortality data (all-cause and cause specific) were collected from the National Cause of Death Register. Data were analyzed using Cox-regression analysis with gender, age, previously established predictors of mortality and comorbid conditions as independent variables, and all-cause mortality and cardiac and respiratory mortality, respectively, as dependent variables.

Results: Out of 241 patients, 155 (64%) were deceased at the end of the study period; 103 patients (66%) died of respiratory disease and 25 (16%) of cardiovascular disease. Impaired kidney function was the only comorbid condition independently associated with increased all-cause mortality (HR (95% CI) 3.41 (1.47-7.93) p=0.004) and respiratory mortality (HR (95%CI) 4.63 (1.61 to 13.4), p = 0.005). In addition, age ≥70, BMI <22 and lower FEV1 expressed as %predicted were significantly associated with increased all-cause and respiratory mortality.

Conclusion: In addition to the risk factors high age, low BMI and poor lung function; impaired kidney function appears to be an important risk factor for mortality in the long term, which should be taken into account in the medical care of patients with severe COPD.

合并症作为严重慢性阻塞性肺病死亡率的预测因素——一项为期8年的随访队列研究
目的:合并症在慢性阻塞性肺疾病(COPD)中很常见,并与发病率和死亡率增加相关。本研究的目的是探讨严重慢性阻塞性肺病中几种合并症的患病率,并调查和比较它们与长期死亡率的关系。方法:2011年5月至2012年3月共纳入241例COPD 3期或4期患者。收集了性别、年龄、吸烟史、体重和身高、目前的药物治疗、最近一年的加重次数和合并症等信息。截至2019年12月31日,从国家死因登记册收集了死亡率数据(全因和特定原因)。数据采用cox回归分析,以性别、年龄、先前确定的死亡率预测因素和合并症为自变量,分别以全因死亡率、心脏和呼吸系统死亡率为因变量。结果:241例患者中,155例(64%)在研究期结束时死亡;103例(66%)死于呼吸系统疾病,25例(16%)死于心血管疾病。肾功能受损是唯一与全因死亡率(HR (95%CI) 3.41 (1.47-7.93) p=0.004)和呼吸系统死亡率(HR (95%CI) 4.63 (1.61 - 13.4), p= 0.005)升高独立相关的共病。结论:除年龄大、BMI低、肺功能差的危险因素外;肾功能受损似乎是长期死亡的一个重要危险因素,在严重慢性阻塞性肺病患者的医疗护理中应考虑到这一点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
15
审稿时长
16 weeks
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信